These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8212440)

  • 21. Use of intracavernosal alprostadil in erectile dysfunction.
    Gingell C
    Hosp Med; 1998 Oct; 59(10):777. PubMed ID: 9850293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of the vasodilator properties of linsidomine chlorhydrate versus isosorbide dinitrate by the intracoronary route].
    Guy JM; Lamaud M; Duranton B; Gerenton C; Berthaud T; Verneyre H
    Ann Cardiol Angeiol (Paris); 1991 Feb; 40(2):103-6. PubMed ID: 2024913
    [No Abstract]   [Full Text] [Related]  

  • 23. The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
    Porst H
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():539-44. PubMed ID: 7732903
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative efficacy of the intravenous administration of linsidomine, a direct nitric oxide donor, and isosorbide dinitrate in severe unstable angina. A French multicentre study. French Group of Investigators.
    Delonca J; Giraud T; Beaufils P; Dupuis B; Haïat R; Théry C
    Eur Heart J; 1997 Aug; 18(8):1300-6. PubMed ID: 9458423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostaglandin E1 in the treatment of erectile insufficiency. Comparison of efficacy and tolerance based on different etiologies].
    Desvaux P; Mimoun S
    J Urol (Paris); 1994; 100(1):17-22. PubMed ID: 7916373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical prostaglandin E1 SEPA gel for the treatment of erectile dysfunction.
    McVary KT; Polepalle S; Riggi S; Pelham RW
    J Urol; 1999 Sep; 162(3 Pt 1):726-30; discussion 730-1. PubMed ID: 10458353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of cross-tolerance to short-term linsidomine in forearm resistance vessels and dorsal hand veins in subjects with nitroglycerin tolerance.
    Sütsch G; Kim JH; Bracht C; Kiowski W
    Clin Pharmacol Ther; 1997 Nov; 62(5):538-45. PubMed ID: 9390110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins.
    Miller VM; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S67-71. PubMed ID: 2484703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [No/PgE1. A new combination in the treatment of erectile dysfunctions].
    Tordjman G
    Contracept Fertil Sex; 1993 Jun; 21(6):509-10. PubMed ID: 7920941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E1 in the therapy of erectile deficiency.
    Beretta G; Zanollo A; Ascani L; Re B
    Acta Eur Fertil; 1989; 20(5):305-8. PubMed ID: 2636808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible hemodynamic pathways of intraurethral prostaglandin-E1 (MUSE).
    Bschleipfer T; Cimniak HU; Beckert R; Hauck EW; Weidner W; Sparwasser C
    Int J Impot Res; 2004 Aug; 16(4):365-8. PubMed ID: 14961055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF; Chu NK; Wong MK
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The intracavernous injection of Edex (prostaglandin E1) in the treatment of erectile impotence in persons in older age groups].
    Gorilovskiĭ LM
    Urol Nefrol (Mosk); 1996; (6):31-3. PubMed ID: 9036606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cultured endothelial cells restore vasodilator responses to coronary arteries with impaired endothelial function and alter the response to a nitric oxide donor.
    Kenny D; Coughlan MG; Kampine JP; Montgomery RR; Bosnjak ZJ; Warltier DC
    Pharmacology; 1994 Oct; 49(4):249-56. PubMed ID: 7831388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thalassaemic men affected by erectile dysfunction treated with transurethral alprostadil: case report.
    Lombardo T; Giammusso B; Frontini V; D'Arpa S; Pafumi C; Caruso S
    Hum Reprod; 2000 Nov; 15(11):2375-8. PubMed ID: 11056136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracavernous pharmacotherapy: comparison of Moxisylyte and prostaglandin E1.
    Buvat J; Lemaire A; Herbaut-Buvat M
    Int J Impot Res; 1996 Jun; 8(2):41-6. PubMed ID: 8858388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
    Govantes C; Rodríguez-Martínez MA; Marín J
    Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group.
    Giuliano F; Montorsi F; Mirone V; Rossi D; Sweeney M
    J Urol; 2000 Sep; 164(3 Pt 1):708-11. PubMed ID: 10953130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-synergistic relaxant effects of vasoactive intestinal polypeptide and SIN-1 in human isolated cavernous artery and corpus cavernosum.
    Hempelmann RG; Papadopoulos I; Herzig S
    Eur J Pharmacol; 1995 Apr; 276(3):277-80. PubMed ID: 7601214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.